Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4582356 | 0.91 | HTT (0.49) | HTTKMT2ASMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL4582338 | 0.90 | SMN1; SMN2 (0.42) | KMT2ASMN1; SMN2LMNARAB9A | |
| SCHEMBL4727929 | 0.86 | ALDH1A1 (0.39) | KMT2ASMN1; SMN2MEN1ALDH1A1MAPT | |
| SCHEMBL4583961 | 0.84 | HTT (0.49) | HTTKMT2ASMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL4584224 | 0.84 | SMN1; SMN2 (0.42) | KMT2ASMN1; SMN2LMNARAB9A | |
| SCHEMBL4581833 | 0.84 | SMN1; SMN2 (0.42) | KMT2ASMN1; SMN2LMNARAB9A | |
| SCHEMBL4583320 | 0.83 | CCNC (0.40) | KMT2AALDH1A1MAPT | |
| SCHEMBL4582536 | 0.83 | KMT2A (0.48) | KMT2ASMN1; SMN2MEN1ALDH1A1MAPT | |
| SCHEMBL4582189 | 0.81 | ALDH1A1 (0.48) | KMT2ASMN1; SMN2MEN1ALDH1A1MAPT | |
| SCHEMBL4725222 | 0.81 | HTT (0.46) | HTTKMT2ASMN1; SMN2MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008028690-A1 | 1-(HET)ARYL-3-[HETARYL-PIPERIDIN-4-YL]-THIOUREAS AS MODULATORS OF THE EP2 RECEPTOR | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-03-13 | — | — | WO | claimed |